Case of pure ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin but responsive to monotherapy with weekly irinotecan
- 16 December 2014
- journal article
- case report
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 41 (5) , 809-812
Abstract
Primary ovarian squamous cell carcinoma is uncommon, and the optimal treatment strategy for this disease has not yet been established. A 71‐year‐old woman diagnosed with FIGO stage IIb pure ovarian squamous cell carcinoma underwent cytoreductive surgery followed by combination chemotherapy with paclitaxel and carboplatin. After the second treatment course, a recurrent mass grew rapidly, and serum tumor maker levels increased. Monotherapy with weekly irinotecan was then instituted. This second‐line chemotherapy was remarkably effective, and the patient subsequently underwent complete interval debulking surgery with a pathological complete response after the third treatment course. Weekly irinotecan is an effective choice for primary ovarian squamous cell carcinoma resistant to combination chemotherapy with paclitaxel and carboplatin.Keywords
This publication has 11 references indexed in Scilit:
- Primary squamous cell carcinoma associated with ovarian endometriosis: a case report and literature reviewInternational Journal of Clinical Oncology, 2011
- Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trialThe Lancet, 2009
- Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroupJournal of Clinical Oncology, 2009
- The safety and efficacy of the weekly dosing of irinotecan for platinum- and taxanes-resistant epithelial ovarian cancerGynecologic Oncology, 2006
- A case of pure-type ovarian squamous cell carcinoma for which combination chemotherapy consisting of paclitaxel and carboplatin was not effectiveGynecologic Oncology, 2005
- Phase II Trial of Irinotecan in Patients With Metastatic Epithelial Ovarian Cancer or Peritoneal CancerJournal of Clinical Oncology, 2003
- A Case of Rapidly Growing Ovarian Squamous Cell Carcinoma Successfully Controlled by Weekly Paclitaxel–Carboplatin AdministrationGynecologic Oncology, 2000
- Remarkable Response of Primary Squamous Cell Carcinoma of the Ovary to Paclitaxel and CisplatinObstetrics & Gynecology, 1998
- Squamous cell carcinoma arising from mature cystic teratoma of the ovary: A clinicopathologic analysisObstetrics & Gynecology, 1997
- Primary Squamous Cell Carcinoma of the OvaryAmerican Journal of Surgical Pathology, 1996